Bio-Techne (TECH) Competitors $47.50 +0.84 (+1.79%) As of 03:38 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TECH vs. A, MTD, WAT, ILMN, BIO, CRL, BRKR, PACB, HBIO, and TMOShould you be buying Bio-Techne stock or one of its competitors? The main competitors of Bio-Techne include Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Rad Laboratories (BIO), Charles River Laboratories International (CRL), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), and Thermo Fisher Scientific (TMO). These companies are all part of the "life sciences tools & services" industry. Bio-Techne vs. Agilent Technologies Mettler-Toledo International Waters Illumina Bio-Rad Laboratories Charles River Laboratories International Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Agilent Technologies (NYSE:A) and Bio-Techne (NASDAQ:TECH) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, dividends, earnings, institutional ownership, community ranking and profitability. Do insiders and institutionals have more ownership in A or TECH? 98.9% of Bio-Techne shares are held by institutional investors. 3.9% of Bio-Techne shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the media favor A or TECH? In the previous week, Agilent Technologies had 22 more articles in the media than Bio-Techne. MarketBeat recorded 37 mentions for Agilent Technologies and 15 mentions for Bio-Techne. Bio-Techne's average media sentiment score of 1.36 beat Agilent Technologies' score of 1.17 indicating that Bio-Techne is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilent Technologies 23 Very Positive mention(s) 2 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Bio-Techne 12 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is A or TECH a better dividend stock? Agilent Technologies pays an annual dividend of $0.99 per share and has a dividend yield of 0.9%. Bio-Techne pays an annual dividend of $0.32 per share and has a dividend yield of 0.7%. Agilent Technologies pays out 22.8% of its earnings in the form of a dividend. Bio-Techne pays out 39.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Agilent Technologies has increased its dividend for 9 consecutive years. Agilent Technologies is clearly the better dividend stock, given its higher yield and longer track record of dividend growth. Which has more volatility & risk, A or TECH? Agilent Technologies has a beta of 1.27, indicating that its share price is 27% more volatile than the S&P 500. Comparatively, Bio-Techne has a beta of 1.46, indicating that its share price is 46% more volatile than the S&P 500. Do analysts recommend A or TECH? Agilent Technologies currently has a consensus target price of $143.00, indicating a potential upside of 31.40%. Bio-Techne has a consensus target price of $73.44, indicating a potential upside of 57.40%. Given Bio-Techne's higher probable upside, analysts clearly believe Bio-Techne is more favorable than Agilent Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Agilent Technologies 0 Sell rating(s) 7 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.46Bio-Techne 0 Sell rating(s) 6 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.40 Is A or TECH more profitable? Agilent Technologies has a net margin of 19.27% compared to Bio-Techne's net margin of 13.22%. Agilent Technologies' return on equity of 25.56% beat Bio-Techne's return on equity.Company Net Margins Return on Equity Return on Assets Agilent Technologies19.27% 25.56% 13.47% Bio-Techne 13.22%12.73%9.75% Which has preferable earnings and valuation, A or TECH? Agilent Technologies has higher revenue and earnings than Bio-Techne. Agilent Technologies is trading at a lower price-to-earnings ratio than Bio-Techne, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAgilent Technologies$6.51B4.77$1.29B$4.3525.02Bio-Techne$1.21B6.05$168.10M$0.8256.90 Does the MarketBeat Community believe in A or TECH? Agilent Technologies received 464 more outperform votes than Bio-Techne when rated by MarketBeat users. Likewise, 71.01% of users gave Agilent Technologies an outperform vote while only 62.19% of users gave Bio-Techne an outperform vote. CompanyUnderperformOutperformAgilent TechnologiesOutperform Votes86771.01% Underperform Votes35428.99% Bio-TechneOutperform Votes40362.19% Underperform Votes24537.81% SummaryAgilent Technologies beats Bio-Techne on 14 of the 21 factors compared between the two stocks. Get Bio-Techne News Delivered to You Automatically Sign up to receive the latest news and ratings for TECH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TECH vs. The Competition Export to ExcelMetricBio-TechneBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.31B$2.93B$5.37B$8.39BDividend Yield0.66%1.72%5.22%4.10%P/E Ratio47.1330.5026.7719.71Price / Sales6.05400.15393.17117.39Price / Cash28.30168.6838.2534.62Price / Book3.553.286.794.50Net Income$168.10M-$72.17M$3.23B$248.18M7 Day Performance-3.28%2.96%1.53%0.20%1 Month Performance-4.93%3.25%10.06%12.37%1 Year Performance-43.77%-28.29%16.74%7.04% Bio-Techne Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TECHBio-Techne4.8435 of 5 stars$47.50+1.8%$73.44+54.6%-43.6%$7.45B$1.21B47.983,000Positive NewsDividend AnnouncementEx-DividendAAgilent Technologies4.8443 of 5 stars$115.53+8.0%$143.00+23.8%-29.2%$32.94B$6.51B26.5617,900Trending NewsUpcoming EarningsAnalyst ForecastMTDMettler-Toledo International4.4708 of 5 stars$1,175.33+8.7%$1,296.13+10.3%-25.6%$24.43B$3.83B29.0018,000News CoveragePositive NewsAnalyst UpgradeWATWaters3.9654 of 5 stars$366.80+6.6%$390.19+6.4%-1.3%$21.83B$2.98B34.258,200Trending NewsAnalyst UpgradeILMNIllumina4.7996 of 5 stars$81.57+7.7%$130.95+60.5%-26.2%$12.91B$4.37B-10.6211,500Analyst ForecastGap DownBIOBio-Rad Laboratories4.8061 of 5 stars$254.32+6.6%$327.40+28.7%-21.1%$7.12B$2.54B-3.918,200Positive NewsCRLCharles River Laboratories International4.907 of 5 stars$143.06+3.1%$176.00+23.0%-39.0%$7.03B$4.02B953.7121,400Positive NewsHigh Trading VolumeBRKRBruker4.9305 of 5 stars$40.26+7.3%$60.10+49.3%-52.3%$6.10B$3.45B52.978,520Dividend AnnouncementAnalyst ForecastHigh Trading VolumePACBPacific Biosciences of California1.6142 of 5 stars$1.10-1.8%$2.50+127.3%-46.4%$330.05M$152.36M-0.67730HBIOHarvard Bioscience3.8209 of 5 stars$0.35+11.8%$4.50+1,178.0%-90.0%$15.57M$94.14M-1.07490Analyst ForecastHigh Trading VolumeTMOThermo Fisher Scientific4.994 of 5 stars$432.16+7.2%$607.43+40.6%-32.6%$163.14B$42.90B26.14130,000Trending NewsDividend AnnouncementAnalyst UpgradeAnalyst RevisionHigh Trading Volume Related Companies and Tools Related Companies A Competitors MTD Competitors WAT Competitors ILMN Competitors BIO Competitors CRL Competitors BRKR Competitors PACB Competitors HBIO Competitors TMO Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TECH) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Techne Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Techne With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TECH Stock Free TECH Stock Alerts